Home          View all 329 MoA classes  

      

Enter a class name or drug name above to search the database.

Proteasome Inhibitors [MoA] Mechanism of Action Drugs

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
0143-9098 bortezomib bortezomib Hikma Pharmaceuticals USA Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-07-27
0409-1700 Bortezomib Bortezomib Hospira, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-07-27
0409-1703 BORTEZOMIB BORTEZOMIB Hospira, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-16
0409-1704 BORTEZOMIB BORTEZOMIB Hospira, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-16
0781-3258 bortezomib bortezomib for injection Sandoz Inc INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-31
10019-991 BORTEZOMIB bortezomib Baxter Healthcare Corporation INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-02
25021-244 BORTEZOMIB BORTEZOMIB Sagent Pharmaceuticals INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-01
25021-262 BORTEZOMIB BORTEZOMIB Sagent Pharmaceuticals INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2025-05-15
31722-303 Bortezomib Bortezomib Camber Pharmaceuticals, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2024-05-03
43598-426 Bortezomib Bortezomib Dr.Reddy's Laboratories, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-07-26
50742-484 Bortezomib Bortezomib Ingenus Pharmaceuticals, LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-01
51817-586 Bortezomib bortezomib Pharmascience Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-02
55150-337 BORTEZOMIB BORTEZOMIB Eugia US LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-02
60505-6050 BORTEZOMIB bortezomib Apotex Corp INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-02
63020-049 VELCADE bortezomib Takeda Pharmaceuticals America, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2003-05-13
63323-821 Bortezomib Bortezomib Fresenius Kabi USA, LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-02
63759-3032 Bortezomib Bortezomib Shilpa Medicare Limited INJECTION 2024-09-25
67184-0530 Bortezomib Bortezomib Qilu Pharmaceutical Co., Ltd. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-02
68001-534 Bortezomib Bortezomib BluePoint Laboratories INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-07-31
68001-540 Bortezomib Bortezomib BluePoint Laboratories INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-16
68001-541 Bortezomib Bortezomib BluePoint Laboratories INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-07-31
70069-836 Bortezomib bortezomib Somerset Therapeutics LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2025-04-29
70121-2484 BORUZU Bortezomib Amneal Pharmaceuticals LLC INJECTION 2024-09-27
70511-161 Bortezomib bortezomib MAIA Pharmaceuticals, Inc. INJECTION 2022-08-11
70511-162 Bortezomib bortezomib MAIA Pharmaceuticals, Inc. INJECTION 2022-08-10
70710-1411 BORTEZOMIB BORTEZOMIB Zydus Pharmaceuticals USA Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-02
70771-1708 BORTEZOMIB BORTEZOMIB Zydus Lifesciences Limited INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-05-02
71288-118 Bortezomib Bortezomib Meitheal Pharmaceuticals Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-07-26
72205-183 Bortezomib Bortezomib Novadoz Pharmaceuticals LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2022-07-26
72338-200 Bortezomib bortezomib Waverley Pharma Inc INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2018-06-19
72603-270 Bortezomib Bortezomib NorthStar RxLLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2024-11-01
76075-101 KYPROLIS carfilzomib Onyx Pharmaceuticals, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2012-07-20
76075-102 KYPROLIS carfilzomib Onyx Pharmaceuticals, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2016-07-15
76075-103 KYPROLIS carfilzomib Onyx Pharmaceuticals, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2018-05-23
83090-008 Bortezomib Bortezomib Sintetica US LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2023-07-15

 Mechanism of Action Classification 

Loading full table content...